Turn/River Capital has injected funds into StarLIMS, a Florida-based enterprise informatics platform that serves a wide array of industries, including life sciences and manufacturing. This move marks a significant shift in StarLIMS' investor landscape as Francisco Partners, a current investor, will exit following this transaction. StarLIMS is renowned for powering manufacturing and research lab operations globally, supporting organizations in the life sciences, CDMOs, food & beverage, chemical, agrochemical, oil & gas, consumer goods, contract testing, R&D, public health, and clinical diagnostics sectors. Led by Trey Cook as CEO, StarLIMS is poised to leverage this investment to expand its market reach and enhance its technology offerings.

This investment underscores Turn/River's confidence in the growing demand for laboratory informatics solutions and StarLIMS' capability to meet those needs. The deal reflects a broader trend in private equity, where investors are increasingly targeting companies that provide critical infrastructure for scientific research and manufacturing processes. The exit of Francisco Partners and the entry of Turn/River suggest a strategic pivot for StarLIMS.

Francisco Partners, known for its focus on technology and tech-enabled services, may be seeking to realize returns after a successful growth phase. In contrast, Turn/River's investment strategy often involves backing companies with strong operational potential, indicating a focus on scaling StarLIMS' capabilities. This transition could signal a new phase of growth for StarLIMS, potentially leading to expanded services and technological advancements.

For Turn/River, this investment aligns with its track record of backing companies in the software and technology sectors, suggesting a bullish outlook on the future of laboratory informatics.